Abstract: According to one aspect, a method of classifying packets includes obtaining at least a first packet on a traffic management arrangement, the traffic management arrangement being implemented on a vehicle, the vehicle including a modem arrangement that includes at least a first modem, wherein obtaining the first packet includes obtaining the first packet from a system onboard the vehicle. The method also includes classifying the first packet using the traffic management arrangement to create a first classified packet, identifying a first quality of service (QoS) tier of a plurality of QoS tiers for the first classified packet, providing the first classified packet with information that identifies the first QoS tier, and providing the first classified packet to the modem arrangement for transmission to a network based on the first QoS tier.

Abstract: According to one aspect, a method includes obtaining a first supervisory request at a teleoperations indirect control arrangement that is originated by a first vehicle that has an autonomy system. The method also includes identifying a first situation associated with the first supervisory request. A first mitigation for the first situation is identified, and it is determined whether the first mitigation includes providing a point-of-intent to the autonomy system. When the first mitigation includes providing the point-of-intent to the autonomy system, the point-of-intent is provided. In response to providing the point-of-intent, a first plurality of potential paths between a current location of the first vehicle and the point-of-intent is obtained. A first potential path of the first plurality of potential paths is selected by the teleoperations indirect control arrangement, and a first indication that the first vehicle is to use the first potential path is provided to the first vehicle.

Abstract: According to one aspect, the routing of an autonomous or semi-autonomous vehicle may be based at least in part upon an ability for a teleoperations system to safely take over the control and operation of the vehicle. A route that is to be driven or traversed by an autonomous vehicle may be created such that geographical areas in which there is substantially inadequate coverage by cellular and/or wireless networks are effectively avoided. By creating routes for an autonomous vehicle that substantially avoid areas of relatively poor cellular and/or wireless network coverage, the ability for the vehicle to safely travel between a source and a destination, even when under the control of a teleoperations system, may be enhanced.

Abstract: According to one aspect, a method includes obtaining, at a monitoring arrangement, a first supervisory request from a first vehicle, the first supervisory request arranged to indicate that the first vehicle has identified a first potential issue. The method also includes processing, at the monitoring arrangement, the first supervisory request, wherein processing the first supervisory request includes determining whether the first potential issue is to be mitigated. When it is determined that the first potential issue is to be mitigated, information is provided from the monitoring arrangement to a control arrangement, and the control arrangement takes control of the first vehicle based on the information.

Abstract: Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione are disclosed. Compositions comprising the polymorphic forms, methods of making the polymorphic forms and methods of their use are also disclosed.

Abstract: Provided are 4?-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.

Abstract: Techniques for image quality enhancement for autonomous vehicle remote operations are disclosed herein. An image processing system of an autonomous vehicle can obtain images captured by at least two different cameras and stitch the images together to create a combined image. The image processing system can apply region blurring to a portion of the combined image to create an enhanced combined image, e.g., to blur regions/objects determined to be less import (or unimportant) for the remote operations. The image processing system can encode pixel areas of the enhanced combined image using a corresponding quality setting for respective pixel areas to create encoded image files, e.g., based on complexity levels of the respective pixel areas. The image processing system can transmit the encoded image files to a remote operations system associated with the autonomous vehicle for remote operations support.

Abstract: Provided are 4?-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.

Abstract: According to one aspect, a method includes identifying, in a scene around a vehicle, at least a first object, wherein the at least first object is identified using data obtained from a sensor system of the vehicle. The method also includes determining a first type associated with the at least first object, identifying at least a first indicator associated with the first type, and providing the at least first indicator associated with the first type to a display arrangement configured to display the scene and the at least first indicator.

Abstract: Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione are disclosed. Compositions comprising the polymorphic forms, methods of making the polymorphic forms and methods of their use are also disclosed.

Abstract: Techniques for image quality enhancement for autonomous vehicle remote operations are disclosed herein. An image processing system of an autonomous vehicle can obtain images captured by at least two different cameras and stitch the images together to create a combined image. The image processing system can apply region blurring to a portion of the combined image to create an enhanced combined image, e.g., to blur regions/objects determined to be less import (or unimportant) for the remote operations. The image processing system can encode pixel areas of the enhanced combined image using a corresponding quality setting for respective pixel areas to create encoded image files, e.g., based on complexity levels of the respective pixel areas. The image processing system can transmit the encoded image files to a remote operations system associated with the autonomous vehicle for remote operations support.

Abstract: Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione are disclosed. Compositions comprising the polymorphic forms, methods of making the polymorphic forms and methods of their use are also disclosed.

Abstract: A pharmaceutical composition comprising (i) a therapeutically effective amount of an inhibitor of the oncogene SLC29A2; and (ii) a pharmaceutically acceptable carrier, for use in suppressing proliferation, occurrence, and metastasis of cancer cells overexpressing the oncogene SLC29A2 in a cancer patient, and/or prolonging cancer patient survival. The inhibitor of the oncogene SLC29A2 may be at least one selected from the group consisting of dipyridamole, dilazep, draflzine, nitorbenzylthioinosine, and the derivatives thereof. The composition for use may further comprise sorafenib for the same use.

Abstract: Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione are disclosed. Compositions comprising the polymorphic forms, methods of making the polymorphic forms and methods of their use are also disclosed.

Abstract: Provided are 4?-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.

Abstract: Provided are 4?-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.

Abstract: Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione are disclosed. Compositions comprising the polymorphic forms, methods of making the polymorphic forms and methods of their use are also disclosed.

Abstract: A pharmaceutical composition comprising (i) a therapeutically effective amount of an inhibitor of the oncogene SLC29A2; and (ii) a pharmaceutically acceptable carrier, for use in suppressing proliferation, occurrence, and metastasis of cancer cells over-expressing the oncogene SLC29A2 in a cancer patient, and/or prolonging cancer patient survival. The inhibitor of the oncogene SLC29A2 may be at least one selected from the group consisting of dipyridamole, dilazep, draflzine, nitorbenzylthioinosine, and the derivatives thereof. The composition for use may further comprise sorafenib for the same use.

Abstract: Provided are 4?-O substituted isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.

Abstract: Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione are disclosed. Compositions comprising the polymorphic forms, methods of making the polymorphic forms and methods of their use are also disclosed.